Rituximab associated late-onset neutropenia—a rheumatology case series and review of the literature

Late-onset neutropenia following rituximab treatment for rheumatologic conditions

(2014) Gabriel S. Breuer et al.   CLINICAL RHEUMATOLOGY

Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab

(2014) R. Abdulkader et al.   JOURNAL OF RHEUMATOLOGY

Rituximabe para o tratamento da artrite reumatoide: Revisão sistemática

(2014) Lívia Lovato Pires de Lemos et al.   Revista Brasileira De Reumatologia

Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Markus Bredemeier et al.   ARTHRITIS CARE & RESEARCH

Cerebral Toxoplasmosis After Rituximab Therapy

(2013) Gilles Safa et al.   JAMA Internal Medicine

Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center

(2012) E. Besada et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

(2011) Daniel Tesfa et al.   ARTHRITIS AND RHEUMATISM

Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms

(2011) Daniel Tesfa et al.   Expert Review of Hematology

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Neutropenia associated with rituximab therapy

(2010) Cliona Grant et al.   CURRENT OPINION IN HEMATOLOGY

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

(2010) R. F. van VOLLENHOVEN et al.   JOURNAL OF RHEUMATOLOGY